BioNTech to invest $43 mn in German facility for mRNA vaccine
The clinical-scale plant has been operational since August 2022 while the commercial-scale one should be ready by end-2023
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.